Skip to main content
Dallah Healthcare Co. logo

Dallah Healthcare Co. — Investor Relations & Filings

Ticker · 4004 ISIN · SA135G51UI10 Saudi Exchange Human health and social work activities
Open in API
Filings indexed 316 across all filing types
Latest filing 2026-05-10 Notice of Dividend Amou…
Country SA Saudi Arabia
Listing Saudi Exchange 4004

About Dallah Healthcare Co.

http://www.dallahhealth.com

Dallah Healthcare Co. operates a network of specialized hospitals and outpatient clinics, including flagship facilities such as Dallah Hospital Al Nakheel and Dallah Hospital Namar. The company provides a broad spectrum of medical services, ranging from inpatient and outpatient care to complex surgical procedures, diagnostic imaging, and laboratory services. In addition to direct patient care, the organization is involved in the distribution of pharmaceutical products and medical supplies. Dallah Healthcare emphasizes clinical excellence and patient safety, utilizing advanced medical technologies and maintaining international quality accreditations. Its service model caters to a diverse demographic, offering specialized treatments across various medical disciplines to meet the needs of both individual and corporate clients.

Recent filings

Filing Released Lang Actions
Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the first quarter of 2026.
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Dallah Healthcare Company regarding the Board of Directors' decision to distribute interim cash dividends for the first quarter of 2026. It includes specific details such as the dividend amount, eligibility date, distribution date, and tax information. The document is relatively short (2872 characters) and focuses solely on dividend distribution details without containing comprehensive financial statements or analysis. Therefore, it is not an Annual Report, Interim Report, or Earnings Release. It is clearly an announcement about dividend payment, fitting the category of Notice of Dividend Amount (DIV).
2026-05-10 English
Dallah Healthcare Co. announces its Interim Financial results for the Period Ending on 2026-03-31 ( Three Months )
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Dallah Healthcare Co. announces its Interim Financial results for the Period Ending on 2026-03-31 (Three Months)', indicating it is an interim financial report covering a quarter (Q1 2026). It contains detailed financial data such as sales/revenue, gross profit, operational profit, net profit, earnings per share, and explanations for changes compared to previous periods. The presence of comprehensive financial tables and management commentary on performance and seasonality confirms it is a substantive financial report rather than a brief announcement or certification. The document length (9664 characters) supports it being a full report rather than a short announcement. Therefore, the document fits the definition of an Interim / Quarterly Report (IR).
2026-05-10 English
Dallah Healthcare Company announces the sale of its shares in Dr. Mohammed Bin Rashed Al Fagih & Partners Company for a value of SAR 497,983,407
Capital/Financing Update Classification · 95% confidence The document is an announcement by Dallah Healthcare Company regarding the sale of its shares in another company, Dr. Mohammed Bin Rashed Al Fagih & Partners Company. It details the transaction terms, parties involved, financial figures related to the transaction, conditions precedent, and expected impact on the company. The document does not contain full financial statements or comprehensive financial performance data of Dallah Healthcare itself, nor is it a transcript, report, or presentation. It is a specific update on a capital transaction involving share sale and purchase agreement (SPA). This fits the definition of a Capital/Financing Update (CAP), which covers updates on company fundraising, financing activities, or capital structure changes. The document length (8468 characters) and detailed transaction information support this classification rather than a brief announcement or a full report.
2026-05-06 English
Dallah Healthcare Company announces recent developments in relation to the acquisition of shares in Al-Ahsa Medical Services Company (Dallah Al-Ahsa Hospital)
M&A Activity Classification · 89% confidence The document is an issuer announcement on the Saudi Exchange detailing Dallah Healthcare’s completion of the acquisition of the remaining share capital of Al-Ahsa Medical Services Company. It describes the takeover bid / merger transaction’s latest developments and completion. This aligns with the M&A Activity category (Code: TAR).
2026-04-23 English
Announcement of Dallah Healthcare Company regarding the Board of Directors’ recommendation to increase the Company’s capital through Issuance of Bonus Shares
Share Issue/Capital Change Classification · 95% confidence The document is an announcement from Dallah Healthcare Company regarding the Board of Directors' recommendation to increase the company's capital through the issuance of bonus shares. It includes details such as the capital before and after increase, percentage increase, number of shares, reasons for the increase, and conditions related to fractional shares and treasury shares. The document is an announcement of a capital change event, not a full financial report or detailed analysis. It is relatively short (3928 characters) and focuses on the capital increase proposal and related approvals. Therefore, it fits the category of Share Issue/Capital Change (SHA).
2026-03-04 English
Dallah Healthcare Company announces the Board of Directors’ decision to distribute interim cash dividends to shareholders for the fourth quarter of 2025.
Notice of Dividend Amount Classification · 100% confidence The document is an announcement from Dallah Healthcare Company regarding the Board of Directors' decision to distribute interim cash dividends for the fourth quarter of 2025. It includes specific details such as the dividend amount, dividend per share, eligibility date, and distribution date. The content focuses solely on dividend distribution information and does not contain financial statements or comprehensive financial analysis. The document length is 2878 characters, which is relatively short and typical for a dividend announcement. Therefore, this document fits the category of Notice of Dividend Amount (DIV).
2026-03-04 English

Browse filings by year

14 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.